ProKidney Corp.
PROK
$1.33
-$0.08-5.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -71.71% | -19.74% | 9.62% | 8.05% | -32.35% |
| Total Depreciation and Amortization | 14.54% | 3.63% | 16.71% | 12.58% | 15.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.20% | -15.93% | 27.91% | -4.42% | 26.10% |
| Change in Net Operating Assets | 49.55% | -571.97% | -95.69% | 584.01% | 74.86% |
| Cash from Operations | -28.51% | -40.86% | -34.51% | 9.05% | 17.96% |
| Capital Expenditure | -23.17% | -233.48% | 77.45% | -116.18% | -389.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.24% | 31.23% | -61.49% | 143.18% | -25.78% |
| Cash from Investing | -31.02% | 23.11% | 86.29% | 135.55% | -35.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 64.29% | 75.00% | 64.29% | 135.71% | -7.69% |
| Issuance of Common Stock | -- | -- | 12,775.18% | 77.99% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,964.29% | 1,891.67% | 14,236.59% | 78.66% | -100.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.08% | -405.10% | 247.35% | 109.76% | -109.89% |